ArticleEuropean heart journal. Cardiovascular pharmacotherapy2021

Cardiac safety and potential efficacy: two reasons for considering minocycline in place of azithromycin in COVID-19 management.

Giovanni Diana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.